Skip to Content

Join the 'Macular Degeneration' group to help and get support from people like you.

Macular Degeneration News

Related terms: Blurry Vision

Supplement May Help Against Vision-Robbing Disease in Seniors

Posted 24 Aug 2017 by Drugs.com

WEDNESDAY, Aug. 23, 2017 – An inexpensive over-the-counter antioxidant/zinc supplement that may help preserve vision in older people is also cost effective, a new study suggests. The combo pill has been dubbed the "Age-Related Eye Disease Study (AREDS)" supplement, based on trial in which it was studied previously. Dr. Aaron Lee, a researcher on the new trial, said his team found AREDS was "greatly cost-effective for the treatment of age-related macular degeneration, specifically in people who have active wet, age-related macular degeneration in one eye and dry in the other." Lee is assistant professor of ophthalmology at the University of Washington in Seattle. Macular degeneration is a progressive disease that's a major cause of vision loss in older Americans. The new study suggests the AREDS supplement may delay the need for more expensive treatment of the "wet" form of the illness, ... Read more

Related support groups: Vitamins, Multivitamin, Multivitamin With Minerals, Macular Degeneration, Metanx, Centrum Multivitamins, Multivitamin With Iron, Multivitamin, Prenatal, Central, Geritol, Cerefolin, Support, Neurobion, Estroven, Cod Liver Oil, Thera, Caltrate 600 with D, Ocuvite, Folbee, StressTabs

Docs May Miss Major Cause of Vision Loss in Seniors

Posted 27 Apr 2017 by Drugs.com

THURSDAY, April 27, 2017 – It's the leading cause of permanent vision loss for Americans, but a condition called age-related macular degeneration (AMD) may be going undiagnosed too often, new research suggests. The new study involved 644 people aged 60 and older who were found to have normal eye health in their most recent examination by either a primary eye care ophthalmologist or optometrist. However, when re-examined by a research team at the University of Alabama at Birmingham, about 25 percent of the study participants showed evidence of age-related macular degeneration. Just why initial exams didn't always pick up the condition remains "unclear," wrote a team led by the university's Dr. David Neely. But, "as treatments for the earliest stages of AMD are developed in the coming years, correct identification of AMD in primary eye care will be critical for routing patients to ... Read more

Related support groups: Macular Degeneration, Visual Defect/Disturbance

For Seniors, Treatment for One Eye Disease May Cause Another

Posted 16 Mar 2017 by Drugs.com

THURSDAY, March 16, 2017 – Drugs that preserve vision in people with the eye disease called age-related macular degeneration might increase the risk of another eye condition – glaucoma, a new study suggests. People who received at least seven eye injections of the drug bevacizumab (Avastin) each year to treat macular degeneration have a higher risk of eventually needing surgery to treat glaucoma, the Canadian study found. But, the researchers aren't suggesting that people forgo these treatments for macular degeneration. These drugs help stave off a previously untreatable cause of blindness in the elderly, and should continue to be used, the researchers said. And, if glaucoma does develop, treatments are available. "Even though there may be a risk here, this doesn't mean you should not be getting injections for macular degeneration," said study lead author Dr. Brennan Eadie. He's an ... Read more

Related support groups: Eye Conditions, Glaucoma, Macular Degeneration, Glaucoma (Open Angle), Votrient, Avastin, Sutent, Nexavar, Pazopanib, Sunitinib, Stivarga, Glaucoma/Intraocular Hypertension, Retinal Disorders, Sorafenib, Cyramza, Bevacizumab, Retinopathy, Lenvima, Inlyta, Ramucirumab

Stem Cells Hold Promise, Peril in Treating Seniors' Eye Disease

Posted 15 Mar 2017 by Drugs.com

WEDNESDAY, March 15, 2017 – Stem cells may offer new hope for people losing their vision to age-related macular degeneration, but that promise can come with some peril, new research shows. In one report, three older women were permanently blinded at a Florida eye clinic that performed unproven stem cell treatments on their eyes in 2015, said senior study author Dr. Jeffrey Goldberg. He's chair of ophthalmology for the Byers Eye Institute at Stanford University in Palo Alto, Calif. The women all thought the stem cell therapy was part of a clinical trial, but there's no evidence that a genuine clinical trial was taking place, Goldberg noted. "It appears the patients were lured in with the promise of a research protocol and it's not clear that they were actually signed up for any research," Goldberg said. "They were just injected with these cells of some sort." The women, aged 72 to 88, ... Read more

Related support groups: Eye Conditions, Macular Degeneration, Macular Edema, Visual Defect/Disturbance

Experimental Drug Shows Promise for Sight-Stealing Eye Condition

Posted 18 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 18, 2017 – An experimental drug may one day make treatment simpler for patients suffering from vision-threatening age-related macular degeneration, researchers say. So far, the drug – called AXT107 – has been only tested on mice and rabbits, but it requires far fewer injections than current therapy to prevent vision loss. Current treatment requires frequent injections directly into the eye. "We anticipate injection of AXT107 in humans may have a substantially longer effect than current treatment," said lead researcher Dr. Peter Campochiaro. He's a professor of ophthalmology at Johns Hopkins University in Baltimore. "Instead of eye injections every four to six weeks, we hope it would be several months between injections," he said. The drug test in rabbits lasted only two months, but the drug appeared both safe and effective, Campochiaro said. Researchers hope to start ... Read more

Related support groups: Eye Conditions, Macular Degeneration, Eylea, Visual Defect/Disturbance, Aflibercept

Mediterranean Diet, Caffeine May Be Good for Your Eyes

Posted 21 Oct 2016 by Drugs.com

THURSDAY, Oct. 20, 2016 – Eating a Mediterranean diet and consuming caffeine may lower your chances of developing age-related macular degeneration (AMD), a leading cause of blindness, according to a new study. Previous research has shown that a Mediterranean diet – high in fruits, vegetables, whole grains, nuts, healthy fats and fish – benefits the heart and lowers cancer risk. But there has been little research on whether it helps protect against eye diseases such as AMD, the researchers noted. Using questionnaires, the researchers assessed the diets of 883 people, aged 55 and older, in Portugal. Of those, 449 had early stage AMD and 434 did not have the eye disease. Closely following a Mediterranean diet was associated with a 35 percent lower risk of AMD, and eating lots of fruit was especially beneficial. The researchers also found that people who consumed high levels of caffeine ... Read more

Related support groups: Dietary Supplementation, Caffeine, Fioricet, Excedrin, Alert, Macular Degeneration, Fiorinal, Excedrin Migraine, Cafergot, Keep Going, Fiorinal with Codeine, Headache Relief, Fioricet with Codeine, Esgic, Norgesic, Acetaminophen/Butalbital/Caffeine, Esgic-Plus, Trezix, Excedrin Extra Strength, Stay Awake

FDA Approves Genentech’s Lucentis (Ranibizumab Injection) Prefilled Syringe

Posted 17 Oct 2016 by Drugs.com

South San Francisco, CA – October 14, 2016 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved the Lucentis (ranibizumab injection) 0.5 mg prefilled syringe (PFS) as a new method of administering the medicine. Like the Lucentis 0.5 mg vial, the 0.5 mg PFS is approved to treat people with wet age-related macular degeneration (AMD) and macular edema after retinal vein occlusion (RVO). The Lucentis PFS is the first syringe prefilled with an anti-VEGF medicine FDA-approved to treat two eye conditions. “The FDA approval of the Lucentis prefilled syringe marks a new milestone in our ongoing commitment to people affected by vision-threatening eye diseases,” said Sandra Horning, M.D., chief medical officer and head of Global Product Development. “With the PFS, physicians will have a new option for adm ... Read more

Related support groups: Macular Degeneration, Lucentis, Macular Edema, Ranibizumab

Blindness Biggest Fear for Many Americans

Posted 4 Aug 2016 by Drugs.com

THURSDAY, Aug. 4, 2016 – Blindness is what many Americans fear most, a new survey shows. "These findings underscore the importance of good eyesight to most and that having good vision is key to one's overall sense of well-being," said lead researcher Dr. Adrienne Scott and colleagues. Scott is an assistant professor of opthalmology at Johns Hopkins University School of Medicine in Baltimore. "The consistency of these findings among the varying ethnic/racial groups underscores the importance of educating the public on eye health and mobilizing public support for vision research," the researchers added in a news release. The nationwide online poll, commissioned by the nonprofit health research group known as Research!America, found that 88 percent of more than 2,000 respondents considered good vision vital to overall health. And 47 percent said losing their sight would have the most ... Read more

Related support groups: Eye Conditions, Smoking, Smoking Cessation, Glaucoma, Cataract, Macular Degeneration, Glaucoma (Open Angle), Retinal Disorders, Glaucoma (Narrow Angle), Visual Defect/Disturbance, Color Vision Defect (Acquired), Glaucoma with Pupillary Block, Refraction - Assessment

Routine Eye Exams See Vision Problems You Miss

Posted 14 Jul 2016 by Drugs.com

WEDNESDAY, July 13, 2016 – Routine eye checkups often pick up unnoticed problems, particularly in older adults, a new study says. "In asymptomatic patients, comprehensive routine optometric eye examinations detect a significant number of new eye conditions and/or results in management changes," said the study's author, Elizabeth Irving, and her colleagues from the University of Waterloo in Ontario, Canada. More than half of people with no new symptoms or vision problems receive new prescriptions or treatment changes as a result of routine eye exams, the researchers found. The need for vision prescription changes was found for two out of five people, the study noted. Meanwhile, 16 percent were diagnosed with a new eye condition and 31 percent had a change in their ongoing care, researchers found. The study included data on nearly 6,400 patients who visited a university eye clinic over ... Read more

Related support groups: Eye Conditions, Glaucoma, Cataract, Macular Degeneration, Glaucoma (Open Angle), Uveitis, Iritis, Keratitis, Optic Nerve Disorder, Corneal Abrasion, Ocular Herpes Simplex, Macular Edema, Corneal Ulcer, Glaucoma/Intraocular Hypertension, Retinal Disorders, Diagnosis and Investigation, Chorioretinitis, Strabismus, Myopia, Diabetic Macular Edema

Health Tip: Help Protect Your Vision

Posted 24 May 2016 by Drugs.com

-- You pay regular visits to your family doctor and dentist, so why not your eye doctor? Regular eye exams can prevent or spot serious problems that could lead to impaired sight. The U.S. Centers for Disease Control and Prevention suggests seeing an eye doctor promptly if you have: Difficulty seeing properly, including double vision. Redness of your eye, draining or eye pain. Floaters, small specks that seem to "float" in front of your eyes. Diabetes. Halos that appear to surround lights. Visions that appear to resemble flashes of light. Read more

Related support groups: Eye Conditions, Glaucoma, Eye Dryness/Redness, Cataract, Macular Degeneration, Conjunctivitis, Retinal Disorders, Eye Redness/Itching, Visual Defect/Disturbance, Vitreomacular Adhesion, Color Vision Defect (Acquired), Refraction - Assessment

Newer Drugs Helping Older People With Eye Disease

Posted 21 May 2016 by Drugs.com

FRIDAY, May 20, 2016 – New medications are boosting quality of life for many older people with age-related macular degeneration (AMD), a new study indicates. The drugs Avastin and Lucentis have significantly increased the number of people with AMD whose vision remains good enough to do daily activities, such as read standard print or drive, researchers found. Age-related macular degeneration is the leading cause of vision loss among older Americans, the U.S. National Eye Institute (NEI) says. Ten years ago, the best available treatment for AMD was photodynamic therapy, which used an intravenous drug and laser treatment to seal off leaking blood vessels in the eye that cause AMD, the researchers explained. However, one year after diagnosis, less than 15 percent of patients who received photodynamic therapy alone had 20/40 vision, which is typically good enough to read standard print or ... Read more

Related support groups: Macular Degeneration, Avastin, Lucentis, Visual Defect/Disturbance

25 Million Americans Will Struggle With Vision Problems by 2050

Posted 19 May 2016 by Drugs.com

THURSDAY, May 19, 2016 – As baby boomers age, the number of Americans with vision problems and blindness is expected to double over the next three decades, a new study suggests. In 2015, slightly more than 12 million Americans had a vision problem. But by 2050, that number will rise to 25 million, the researchers predicted. "This study gives us a GPS for our nation's future eye health," said lead researcher Dr. Rohit Varma, a professor of ophthalmology at the University of Southern California Keck School of Medicine in Los Angeles. "Our group and others have shown in previous studies that those who suffer from vision loss not only have a decreased quality of life but can also experience both physical and mental health decline, including an increased risk for chronic health conditions such as diabetes, depression and even death," he said. The economic burden from vision loss and eye ... Read more

Related support groups: Glaucoma, Cataract, Macular Degeneration, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Visual Defect/Disturbance, Aphakia, Pseudophakia, Glaucoma with Pupillary Block

Experts Undecided on Whether Seniors Should Get Routine Vision Checks

Posted 1 Mar 2016 by Drugs.com

TUESDAY, March 1, 2016 – There's just not enough good data to say whether or not seniors should be routinely screened for vision trouble by their primary care physicians, an influential panel of U.S. experts reports. The U.S. Preventive Services Task Force (USPSTF) believes current data isn't adequate to assess the potential benefits and harms of such screening in people 65 or older. The task force is an independent, volunteer panel of experts that reviews the scientific evidence and makes recommendations on preventive health services. "We need more evidence on accurate ways to screen for eye conditions in older adults in a primary care setting," task force chair Dr. Al Siu said in a USPSTF news release. Siu is Mount Sinai Health System chair, and a professor in the department of geriatrics and palliative medicine at the Icahn School of Medicine at Mount Sinai, in New York City. ... Read more

Related support groups: Eye Conditions, Cataract, Macular Degeneration, Macular Edema, Visual Defect/Disturbance, Myopia, Diabetic Macular Edema, Color Vision Defect (Acquired)

Study Compares Drugs for Common Diabetic Eye Disease

Posted 29 Feb 2016 by Drugs.com

MONDAY, Feb. 29, 2016 – People with diabetes are at risk for blurred vision or even a loss of vision from a condition called macular edema. Three drugs for the disease – Avastin, Eylea and Lucentis – vary widely in price, but new research suggests all work equally well for patients with mild vision loss. However, when diabetic macular edema leads to more severe vision loss, researchers found Eylea to be the better choice. The study, funded by the U.S. National Eye Institute (NEI), "will help doctors and their patients with diabetic macular edema choose the most appropriate therapy," study lead author Dr. John Wells said in an institute news release. "The study suggests there is little advantage of choosing Eylea or Lucentis over [much cheaper] Avastin when a patient's loss of visual acuity from macular edema is mild, meaning a visual acuity of 20/40 or better," Wells explained. ... Read more

Related support groups: Eye Conditions, Macular Degeneration, Avastin, Diabetes Mellitus, Lucentis, Macular Edema, Eylea, Abnormal Glucose Tolerance, Bevacizumab, Visual Defect/Disturbance, Diabetic Macular Edema, Ranibizumab, Aflibercept

Health Tip: Putting Medicine in Your Eyes

Posted 16 Feb 2016 by Drugs.com

-- You may be wary about applying those new eyedrops prescribed by your doctor. The Cleveland Clinic recommends: Use warm water and soap to wash your hands, then dry with a clean towel. Either grab a mirror or lie down before applying the medicine. Look up at the ceiling, then use one hand to pull down the lower eyelid. Hold the medicine in your other hand, resting on your forehead if needed. Without letting the tip of the bottle or tube touch the eye, gently place the medicine inside your lower eyelid. Then close your eye. If you are taking both an ointment and an eye drop, put the eye drop in first. Wait about five minutes before applying the ointment. Read more

Related support groups: Eye Conditions, Glaucoma, Eye Dryness/Redness, Macular Degeneration, Glaucoma (Open Angle), Conjunctivitis, Conjunctivitis - Bacterial, Blepharitis, Keratitis, Ocular Herpes Simplex, Corneal Ulcer, Corneal Abrasion, Glaucoma/Intraocular Hypertension, Eye Redness/Itching, Conjunctivitis - Allergic, Seasonal Allergic Conjunctivitis, Glaucoma (Narrow Angle), Herpes Simplex Dendritic Keratitis, Blepharoconjunctivitis, Glaucoma with Pupillary Block

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Eye Conditions

Related Drug Support Groups

Lucentis, Eylea, bevacizumab, Visudyne, Macugen, pegaptanib, ranibizumab, verteporfin, aflibercept